Trials / Conditions / Lymphangioleiomyomatosis (LAM)
Lymphangioleiomyomatosis (LAM)
5 registered clinical trials studyying Lymphangioleiomyomatosis (LAM) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM) NCT06889168 | Columbia University | Phase 1 |
| Recruiting | Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosi NCT07304856 | University of Milan | — |
| Completed | Glutamine PET Imaging in LAM NCT04388371 | Vanderbilt University Medical Center | Phase 1 |
| Completed | COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC NCT02484664 | Brigham and Women's Hospital | Phase 2 |
| Completed | Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous NCT00790400 | Novartis Pharmaceuticals | Phase 3 |